Search Results for "Quantos Anos Dura O Curso De Farmacia"

17:56 EDT 8th October 2015 | BioPortfolio

Matching Channels


Matching News

Tweet of the Week: 3D-Printed Brain Matter

(MedPage Today) -- Push a button and, voila, dura tissue. Well, almost

Admedus Limited expands market for ADAPT® tissue products

Admedus Limited (ASX:AHZ) is expanding its regenerative tissue portfolio into additional large target repair markets following successful initial results from a pre-clinical study of ADAPT® treate...

DePuy Synthes CMF Launches First Biosynthesized Cellulose-Based Dural Replacement For Neurosurgery

WEST CHESTER, Pa., May 4, 2015 /PRNewswire/ -- DePuy Synthes CMF* today announced the launch of SYNTHECEL® Dura Repair, the first commercially available biosynthesized dural replacement derived f...

Tienda Diabetes' Farmacia Online, Mexico's First Online Pharmacy, Tackles Fight Against Diabetes with IBM Commerce

MEXICO CITY, Aug. 12, 2015 /PRNewswire/ -- IBM (NYSE: IBM) today announced its collaboration with Tienda Diabetes, a leading Mexican healthcare provider, to provide diabetes patients with af...

Chinese 3D company prints world’s first biological Dura for use in brain surgery

SOURCE July 21, 2015 While 3D bioprinting innovations sound life-saving and revolutionary, most are still years away from impacting ordinary people in regular hospitals. However, one Chinese company i...

DePuy Synthes launches cellulose-based dural replacement for neurosurgery

DePuy Synthes CMF announced the launch of SYNTHECEL Dura Repair, the first commercially available biosynthesized dural replacement derived from cellulose for use in neurosurgery.

Stretchy spinal implant presents new paralysis treatment

A thin and flexible implant that can be applied directly to the surface of the spinal cord to administer electrical and chemical stimulation has been developed by scientists in Switzerland. The e-Dura...

Admedus receives A$0.20 price target from Morgans

Admedus Limited (ASX:AHZ) remains one of Morgans’ High Conviction calls in 2015, which also has an Add recommendation with a price target of A$0.20.The broker noted that with the A$28 million ca...

Matching PubMed Articles

Search Whole site using Google


Advertisement Advertisement